Clinical Trials Browser

Phase 1/2 × Solid Tumor × SHR-1701 × Clear all

NCT04679038 2022-01-26

A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor